BlueCrest Capital Management’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-14,967
| Closed | -$1.49M | – | 461 |
|
|
2019
Q3 | $1.49M | Buy |
14,967
+9,318
| +165% | +$927K | 0.1% | 136 |
|
|
2019
Q2 | $616K | Buy |
+5,649
| New | +$616K | 0.04% | 186 |
|
|
2019
Q1 | – | Sell |
-26,257
| Closed | -$2.53M | – | 1242 |
|
|
2018
Q4 | $2.53M | Buy |
26,257
+15,060
| +135% | +$1.45M | 0.13% | 111 |
|
|
2018
Q3 | $1.37M | Sell |
11,197
-65,015
| -85% | -$7.93M | 0.04% | 336 |
|
|
2018
Q2 | $8.37M | Buy |
76,212
+64,237
| +536% | +$7.05M | 0.22% | 82 |
|
|
2018
Q1 | $1.28M | Sell |
11,975
-92,804
| -89% | -$9.9M | 0.04% | 394 |
|
|
2017
Q4 | $11.2M | Sell |
104,779
-144,296
| -58% | -$15.4M | 0.3% | 53 |
|
|
2017
Q3 | $27.7M | Buy |
249,075
+182,997
| +277% | +$20.3M | 1.13% | 8 |
|
|
2017
Q2 | $6.83M | Buy |
+66,078
| New | +$6.83M | 0.26% | 108 |
|
|
2017
Q1 | – | Sell |
-92,799
| Closed | -$8.21M | – | 823 |
|
|
2016
Q4 | $8.21M | Buy |
+92,799
| New | +$8.21M | 0.45% | 50 |
|
|
2016
Q3 | – | Sell |
-59,388
| Closed | -$5.09M | – | 808 |
|
|
2016
Q2 | $5.09M | Buy |
+59,388
| New | +$5.09M | 0.21% | 101 |
|
|
2016
Q1 | – | Hold |
0
| – | – | – | 871 |
|
|
2015
Q4 | – | Sell |
-53,358
| Closed | -$5.4M | – | 1025 |
|
|
2015
Q3 | $5.4M | Buy |
+53,358
| New | +$5.4M | 0.18% | 80 |
|
|
2015
Q1 | – | Hold |
0
| – | – | – | 631 |
|
|
2014
Q4 | – | Hold |
0
| – | – | – | 559 |
|